Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Gallium Nitrate in CF patients with NTM
NCT04294043Phase 1Recruiting
- Start
- Jun 2021
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of gallium nitrate in nontuberculous mycobacteria infection (2 cohorts). Primary endpoint: Adverse Events of Special Interest. Started Jun 2021; status: recruiting.
02
Drugs
gallium nitrate
03
Conditions
nontuberculous mycobacteria infection
Beyond the preview
Go deeper on NCT04294043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04294043.